Search research articles
Contact Us
Filters
Showing results (471-480 of 562) with videos related to
Page
of 57
Sort By:
The Journal of Clinical Investigation
|
April 10, 2008
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
Stefan Pfister, Wibke G Janzarik, Marc Remke, et al.
Neuro-Oncology
|
October 11, 2017
Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation
Tobias Kessler, Felix Sahm, Ahmed Sadik, et al.
Journal of Neuro-Oncology
|
July 10, 2024
A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases
Sebastian Jeising, Ann-Christin Nickel, Johanna Trübel, et al.
Nature Communications
|
December 19, 2020
Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype
Yonghe Wu, Michael Fletcher, Zuguang Gu, et al.
Acta Neuropathologica
|
August 14, 2012
Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations
Xiao-Yang Liu, Noha Gerges, Andrey Korshunov, et al.
The Lancet. Oncology
|
August 30, 2024
The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect group
Philipp Karschnia, Jasper K W Gerritsen, Nico Teske, et al.
Journal of Neuro-Oncology
|
July 7, 2022
Mid-term treatment-related cognitive sequelae in glioma patients
Sabine Schlömer, Jörg Felsberg, Milena Pertz, et al.
International Journal of Cancer
|
October 28, 2020
MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial
Theophilos Tzaridis, Niklas Schäfer, Johannes Weller, et al.
Acta Neuropathologica
|
October 21, 2015
Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity
Andrey Korshunov, David Capper, David Reuss, et al.
Neuro-Oncology
|
July 3, 2016
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide
Wolfgang Wick, Patrick Roth, Christian Hartmann, et al.
Page
of 57
Search research articles
Search
Showing results (471-480 of 562) with videos related to
Sort By:
Page
of 57
The Journal of Clinical Investigation
|
April 10, 2008
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
Stefan Pfister, Wibke G Janzarik, Marc Remke, et al.
Neuro-Oncology
|
October 11, 2017
Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation
Tobias Kessler, Felix Sahm, Ahmed Sadik, et al.
Journal of Neuro-Oncology
|
July 10, 2024
A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases
Sebastian Jeising, Ann-Christin Nickel, Johanna Trübel, et al.
Nature Communications
|
December 19, 2020
Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype
Yonghe Wu, Michael Fletcher, Zuguang Gu, et al.
Acta Neuropathologica
|
August 14, 2012
Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations
Xiao-Yang Liu, Noha Gerges, Andrey Korshunov, et al.
The Lancet. Oncology
|
August 30, 2024
The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect group
Philipp Karschnia, Jasper K W Gerritsen, Nico Teske, et al.
Journal of Neuro-Oncology
|
July 7, 2022
Mid-term treatment-related cognitive sequelae in glioma patients
Sabine Schlömer, Jörg Felsberg, Milena Pertz, et al.
International Journal of Cancer
|
October 28, 2020
MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial
Theophilos Tzaridis, Niklas Schäfer, Johannes Weller, et al.
Acta Neuropathologica
|
October 21, 2015
Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity
Andrey Korshunov, David Capper, David Reuss, et al.
Neuro-Oncology
|
July 3, 2016
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide
Wolfgang Wick, Patrick Roth, Christian Hartmann, et al.
Page
of 57